Cargando…
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells
People with cystic fibrosis should be considered at increased risk of developing severe symptoms of COVID-19. Strikingly, a broad array of evidence shows reduced spread of SARS-CoV-2 in these subjects, suggesting a potential role for CFTR in the regulation of SARS-CoV-2 infection/replication. Here,...
Autores principales: | Lotti, Virginia, Merigo, Flavia, Lagni, Anna, Di Clemente, Andrea, Ligozzi, Marco, Bernardi, Paolo, Rossini, Giada, Concia, Ercole, Plebani, Roberto, Romano, Mario, Sbarbati, Andrea, Sorio, Claudio, Gibellini, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028056/ https://www.ncbi.nlm.nih.gov/pubmed/35456026 http://dx.doi.org/10.3390/cells11081347 |
Ejemplares similares
-
WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
por: Lotti, V., et al.
Publicado: (2022) -
Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells
por: Merigo, Flavia, et al.
Publicado: (2022) -
439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
por: Sorio, C., et al.
Publicado: (2022) -
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2
por: Lagni, Anna, et al.
Publicado: (2023) -
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
por: Lotti, Virginia, et al.
Publicado: (2023)